Prawo i regulacje · 06/07/2015

Navinta, LLC Seeks DEA Approval for Bulk Manufacturing of Controlled Substances

Navinta, LLC has submitted a bulk manufacturer of controlled substances application to the U.S. Drug Enforcement Administration (DEA). The company aims to manufacture and distribute controlled substances, such as naloxone, for the treatment of opioid overdose.